Candiolo Cancer Institute, FPO-IRCCS, also known as Fondazione del Piemonte per l'Oncologia, is a private non-profit oncology research hospital in Candiolo, Italy. Founded in 1996, it was designated an IRCCS by the Italian Ministry of Health in 2013 for excellence in cancer research and care.
The institute focuses on the diagnosis, treatment, and scientific study of oncological diseases, combining clinical services with translational research. It participates in the Piedmont and Aosta Valley Oncology Network and holds memberships in the Alliance Against Cancer and the European Organization of Cancer Institutes as a Comprehensive Cancer Centre.
Also known as Istituto di Candiolo - FPO IRCCS, Fondazione del Piemonte per l'Oncologia (FPO), and IRCCS Istituto Oncologico di Candiolo.
None yet. When a new project in the record names Candiolo Cancer Institute as owner, partner or investor, it shows here.
Fixed‑duration subcutaneous epcoritamab produced rapid, durable responses and high MRD negativity in elderly newly diagnosed DLBCL patients ineligible for full‑dose anthracycline therapy.
